Radiological diagnosis and follow-up of pulmonary tuberculosis

Mycobacterium tuberculosis, the causal organism of tuberculosis (TB), is one of the oldest and still one of the deadliest pathogens known to man. Approximately 1 in 10 people with primary pulmonary tuberculosis (PTB) present clinically; of untreated cases, approximately 1 in 10 reactivate usually at a time of relative immunodeficiency. The spectrum of radiologic manifestations of PTB can pose a variety of diagnostic and management challenges. PTB infection often leaves long term sequelae of infection, particularly granulomatous nodules, cavitation, and fibrosis; distinguishing dormant disease from reactivation is not always clear-cut. The radiologic presentation of primary PTB infection tends to differ from that of post-primary PTB, but there is significant overlap in the appearances. Primary PTB typically presents with consolidation and regional lymphadenopathy, whereas post-primary PTB more often results in cavitation. The pathology and therefore the radiology of TB infection will be altered based on the efficacy of the immune response and will therefore vary depending on the immune competency. Clinically, in the presence of infection, the main questions are whether M tuberculosis is the infecting organism and, if treated, does the radiology indicate response to treatment. In order to interpret the radiology of TB one needs to be aware of the spectrum of presentation, the expected reaction to treatment, and the myriad of non-pulmonary sites of infection that may prove to be more clinically significant than the pulmonary infection.

[1]  A. Weber,et al.  Primary tuberculosis in childhood with particular emphasis o hanges affecting the tracheobronchial tree. , 1968, The American journal of roentgenology, radium therapy, and nuclear medicine.

[2]  R. G. Fraser DIAGNOSIS OF DISEASES OF THE CHEST , 1978, The Ulster Medical Journal.

[3]  R. Chaisson,et al.  Human immunodeficiency virus infection in tuberculosis patients. , 1990, The Journal of infectious diseases.

[4]  A+A+F , 1964 .

[5]  J P Matts,et al.  Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Stead,et al.  The history of tuberculosis as a global epidemic. , 1993, The Medical clinics of North America.

[7]  S. P. Akpabio World Health Organisation , 1983, British Dental Journal.

[8]  Kyoung Soo Lee,et al.  Thoracic sequelae and complications of tuberculosis. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  T. Williams,et al.  Update: the radiographic features of pulmonary tuberculosis. , 1986, AJR. American journal of roentgenology.

[10]  D. D. Des Jarlais,et al.  Tuberculosis in drug users. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Erasmus,et al.  Radiologic manifestations of pulmonary tuberculosis. , 1995, Radiologic clinics of North America.

[12]  J. Amorosa,et al.  The air-fluid level in cavitary pulmonary tuberculosis. , 1978, Radiology.

[13]  P. Hopewell A clinical view of tuberculosis. , 1995, Radiologic clinics of North America.

[14]  F. Verhaegen,et al.  High resolution chest CT in tuberculosis: evolutive patterns and signs of activity. , 1997, Journal of computer assisted tomography.

[15]  A. Leung Pulmonary tuberculosis: the essentials. , 1999, Radiology.

[16]  N. Müller,et al.  Primary tuberculosis in childhood: radiographic manifestations. , 1992, Radiology.

[17]  N. Müller,et al.  Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. , 1994, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[18]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.